Some good news for those Type 1 folks out there like myself.
https://bioinformant.com/sernova-biotherapeutics-phase-1-2-clinical-trial-of-cell-pouch/
Here's what it means for us.
Sernova is making big moves in the race for a practical cure for Type 1 diabetes. They’re advancing clinical trials on their Cell Pouch—a tiny, implantable device that lets transplanted islet cells survive and actually do their insulin-producing job. Right now, they’re finishing up tests with donor islets, but the real game-changer is what comes next: working with lab-grown, stem cell–derived islets. Why should you care? Because this tech could mean no more waiting on donor shortages and opens the door to a scalable, widely available cell therapy—potentially insulin independence for more people living with T1D.
Bottom line: Sernova’s approach isn’t just about treating diabetes—it’s about aiming for a life where diabetes doesn’t control you. That’s news worth following.